Jump to Main Content

Meetings

Schedule and Program for the ASH Meeting on Hematologic Malignancies

The following program corresponds to the 2019 ASH Meeting on Hematologic Malignancies.

  • 7:00 a.m.  Registration, Breakfast, and Exhibits 
     7:45 a.m.  Welcome and Opening Remarks
     8:00 a.m.  How I Treat Young Adults with Acute Lymphoblastic Leukemia
    Anjali Advani, MD, Cleveland Clinic
     8:30 a.m.  How I Treat Acute Lymphoblastic Leukemia with Incorporation of Novel Therapies 
    Jae H. Park, MD, Memorial Sloan Kettering Cancer Center
     9:00 a.m.  How I Diagnose Patients with AML Based on Minimal Residual Disease Testing
    Brent Wood, MD, PhD, University of Washington
     9:30 a.m.  Panel Discussion with Drs. Advani, Park, and Wood
     10:00 a.m.  Networking Coffee Break and Exhibits
     10:30 a.m.  Special Education Program Session: Controversial Cases in AML
    Gail Roboz, MD, Weill Cornell Medicine
    Jessica Altman, MD, Northwestern University
    Harry Erba, MD, PhD, Duke University
     11:30 a.m.  Special Education Program Session Panel Discussion with Drs. Roboz, Altman, and Erba
     12:00 p.m.  Lunch with the Experts (General Lunch Available)
     1:15 p.m.  How I Treat Patients with Low Grade Myelodysplastic Syndromes
    Amer Zeidan, MD, Yale University
     1:45 p.m.  How I Treat Patients with High Grade Myelodysplastic Syndromes
    Amy DeZern, MD, Johns Hopkins University
     2:15 p.m.  Panel Discussion with Drs. Zeidan and DeZern
     2:45 p.m.  Networking Coffee Break and Exhibits
     3:15 p.m.  How I Approach CML TKI Discontinuation
    Neil Shah, MD, PhD, University of California – San Francisco
     3:45 p.m.  How I Identify and Treat MF Patients With Ruxolitinib Failure
    John Mascarenhas, MD, Mount Sinai School of Medicine
     4:15 p.m.  Panel Discussion with Drs. Shah and Mascarenhas
     4:45 p.m.  How I Treat Newly Diagnosed Hodgkin Lymphoma
    Andy Evens, DO, Rutgers University
     5:15 p.m.  How I Treat Relapsed Hodgkin Lymphoma
    Stephen Ansell, MD, PhD, Mayo Clinic
     5:45 p.m.  Panel Discussion with Drs. Evens and Ansell
     6:15 p.m.  Program Concludes for the Day
  •  7:00 a.m. Registration, Breakfast, and Exhibits 
     7:45 a.m.  Welcome and Opening Remarks
     8:00 a.m.  How I Treat Newly Diagnosed, Relapsed, and Transformed CLL Patients
    Jose Leis, MD, PhD, Mayo Clinic
     8:30 a.m.  DLBCL – Does the Molecular Classification Really Inform Therapy?
    Kieron Dunleavy, MD, George Washington University
     9:00 a.m.  T-cell Lymphoma – How Should I Use New Agents in My Practice?
    Neha Mehta-Shah, MD, Washington University in St. Louis
     9:30 a.m.  Panel Discussion with Drs. Dunleavy, Mehta-Shah, and Leis
     10:00 a.m.  Networking Coffee Break and Exhibits
     10:30 a.m.  How I Treat Follicular Lymphoma 
    John Leonard, MD, Weill Cornell Medicine
     11:00 a.m.  Marginal Zone Lymphoma – What Does the Biology Teach Us?
    Sonali Smith, MD, University of Chicago
     11:30 a.m.  Mantle Cell Lymphoma – What Treatment Should I Choose for A Newly Diagnosed Patient?
    Brad Kahl, MD, Washington University School of Medicine in St. Louis
     12:00 noon  Panel Discussion with Drs. Leonard, Smith, and Kahl
     12:30 p.m.  Lunch with the Experts (General Lunch Available)
     1:45 p.m.  How I Treat Smoldering Myeloma
    Irene Ghobrial, MD, Dana-Farber Cancer Institute
     2:15 p.m.  How I Treat Refractory Myeloma
    Jesus Berdeja, MD, Sarah Cannon Research Institute
     2:45 p.m.  Panel Discussion with Drs. Ghobrial and Berdeja
     3:15 p.m.  Networking Coffee Break and Exhibits
     3:45 p.m.  Special Education Program Session: Controversies in the Management of Newly Diagnosed Multiple Myeloma
    S. Vincent Rajkumar, MD, Mayo Clinic
    Michaela Liedtke, MD, Stanford University
    Prashant Kapoor, MD, Mayo Clinic
     4:45 p.m.  Special Education Program Session Panel Discussion with Drs. Rajkumar, Liedtke, and Kapoor
     5:15 p.m.  Program Concludes